Cabio Biotech (Wuhan) Co., Ltd. (688089) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cabio Biotech (Wuhan) Co., Ltd.

Why is Cabio Biotech (Wuhan) Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 13.50% and Operating profit at 10.26% over the last 5 years

INTEREST(HY) At CNY 0.99 MM has Grown at 389.7%
INTEREST COVERAGE RATIO(Q) Lowest at 6,043.31
PRE-TAX PROFIT(Q) At CNY 25.37 MM has Fallen at -46%

With ROE of 10.11%, it has a fair valuation with a 2.68 Price to Book Value

Over the past year, while the stock has generated a return of -18.68%, its profits have risen by 36.5% ; the PEG ratio of the company is 0.7
At the current price, the company has a high dividend yield of 0.8

Below par performance in long term as well as near term

Along with generating -18.68% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cabio Biotech (Wuhan) Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Cabio Biotech (Wuhan) Co., Ltd.

-100.0%

0.77

45.54%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.91%

EBIT Growth (5y)

-12.87%

EBIT to Interest (avg)

86.76

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.11

Sales to Capital Employed (avg)

0.32

Tax Ratio

13.92%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

10.13%

ROE (avg)

7.71%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.28

EV to EBIT

33.34

EV to EBITDA

17.82

EV to Capital Employed

1.32

EV to Sales

4.44

PEG Ratio

Dividend Yield

1.66%

ROCE (Latest)

3.95%

ROE (Latest)

3.16%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 224.93 MM

-44What is not working for the Company

INTEREST(HY)

At CNY 1.45 MM has Grown at 497.89%

ROCE(HY)

Lowest at 3.46%

RAW MATERIAL COST(Y)

Grown by 317.52% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.12 times

NET SALES(Q)

Lowest at CNY 11.01 MM

OPERATING PROFIT(Q)

Lowest at CNY -41.84 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -379.85 %

PRE-TAX PROFIT(Q)

Lowest at CNY -44.65 MM

NET PROFIT(Q)

Lowest at CNY -43.11 MM

EPS(Q)

Lowest at CNY -0.26

Here's what is working for Cabio Biotech (Wuhan) Co., Ltd.

Operating Cash Flow

Highest at CNY 224.93 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for Cabio Biotech (Wuhan) Co., Ltd.

Interest

At CNY 1.45 MM has Grown at 497.89%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 11.01 MM has Fallen at -92.18%

over average net sales of the previous four periods of CNY 140.78 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -44.65 MM has Fallen at -206.52%

over average net sales of the previous four periods of CNY 41.92 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -43.11 MM has Fallen at -216.84%

over average net sales of the previous four periods of CNY 36.89 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 11.01 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY -41.84 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -379.85 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY -44.65 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -43.11 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.26

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Lowest at 1.12 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 317.52% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales